US Patent

US10251895 — Topical compositions and methods for treating psoriasis

Formulation · Assigned to Valeant Pharmaceuticals North America LLC · Expires 2036-06-06 · 10y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects topical pharmaceutical compositions that combine a corticosteroid and a retinoid for treating psoriasis.

USPTO Abstract

Topical pharmaceutical compositions comprise a combination of a corticosteroid a retinoid; and methods for treating psoriasis with same.

Drugs covered by this patent

Patent Metadata

Patent number: US10251895
Jurisdiction: US
Classification: Formulation
Expires: 2036-06-06
Drug substance claim: No
Drug product claim: Yes
Assignee: Valeant Pharmaceuticals North America LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.